Walleye Capital LLC Lexicon Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.31 - $2.69 $263,268 - $540,603	-200,968 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $391,887 - $781,765	200,968 New	200,968 $420,000
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $71,688 - $102,138	-17,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $60,030 - $158,166	17,400 New	17,400 $102,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $145M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.